0,1
6.4.8 Guidelines for the first-line treatment of hormone-sensitive metastatic disease*,
Recommendations,Strength rating
"In pN0 patients with ISUP grade group 4–5 and pT3 ± positive margins, offer adjuvant 
intensity-modulated radiation therapy (IMRT)/volumetric modulated arc therapy (VMAT) 
plus image-guided radiation therapy (IGRT).",Strong
"In pN1 patients, after an extended lymph node dissection, discuss three 
management options, based on nodal involvement characteristics:
1.  Offer adjuvant ADT;
2.  Offer adjuvant ADT with additional IMRT/VMAT plus IGRT;
3.   Offer observation (expectant management) to a patient after eLND and  
< 2 nodes and a PSA < 0.1 ng/mL.",Weak
